检索

标题
作者
The clinician's view on the advantages and contradictions of the new nomenclature of steatotic liver disease: A review
Pavlov C., Teplyuk D., Lazebnik L., Ametov A., Pashkova E., Sorokoletov S., Uspenskiy Y., Turkina S., Ponomarenko E., Maslakov A.
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions
Toktogulova N., Sultanalieva R., Tuhvatshin R., Kaliev T.
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
Demidova T., Ushanova F.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
The study of abdominal and parietal enteric microbiota in patients with non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A., Lyapina M.
Modification of dietary patterns in patients with non-alcoholic steatohepatitis
Sasunova A., Goncharov A., Morozov S., Isakov V.
Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
Goncharov A., Sasunova A., Pilipenko V., Isakov V.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K., Belyy P., Maev I., Klimova E., Shutko S., Znoyko O., Yuschuk N.
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M., Vorobyev S., Butova H.
Mixed steatohepatitis: more questions than answers (part 2)
Raikhelson K., Kondrashina E., Pazenko E.
Mixed steatohepatitis: more questions than answers (Part 1)
Raikhelson K., Kondrashina E., Pazenko E.
Obesity as a risk factor for diseases of the digestive system
Andreev D., Kucheryavyy Y.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease
Cherkashchenko N., Livzan M., Krolevets T.
Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease
Cherkashchenko N., Livzan M., Krolevets T.
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
Nosov A., Zenina M., Gorbushina O., Baidina A., Vlasova E., Alekseev V.
Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
Pavlov A., Ivolgin A., Katenko S., Eremin M., Molodova A., Levchenko O., Karakozov A.
Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome
Severova M., Fomin V., Lebedeva M., Sorokin Y., Saginova E., Minakova E., Gallyamov M., Mukhin N.
The importance of the bacterial overgrowth syndrome in the development of disorders metabolic functions of the liver in non-alcoholic fatty liver disease
Vakhrushev Y., Lukashevich A.
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
Akhmedov V., Gaus O.
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
Maevskaya M., Ivashkin V., Ivashkin K., Lunkov V., Liusina E., Zozula V., Leshchenko V.
Optimizing therapy of liver diseases not associated with viral infection
Svistunov A., Osadchuk M., Kireeva N., Osadchuk M.
Evaluation of the efficiency of hepatoprotective monotherapy using succinic acid and methionine for nonalcoholic fatty liver disease at the stage of steatohepatitis
Semiserin V., Karakozov A., Malkuta M., Zolotareva L., Levchenko O., Kalyagin I., Eremin M.
Evaluation of endothelial function and estimation of the degree of apoptosis in patients with metabolic syndrome and non-alcoholic fatty liver disease
Drapkina O., Deeva T., Ivashkin V.
Intrahepatic cholestasis in nonalcoholic fatty liver disease
Shipovskaya A., Dudanova O.
Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity
Komshilova K., Troshina E., Ershova E., Mazurina N., Platonova N.
1 - 28 的 28 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##